Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature

Bibliography

• Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-6
   PubMed Web of Science ®Google Scholar
• Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med 2006;47:373-80
   PubMed Web of Science ®Google Scholar
• Tang AW. A practical guide to anaphylaxis. Am Fam Physician 2003;68:1325-32
   PubMed Web of Science ®Google Scholar
• Laroche D, Namour F, Lefrancois C, et al. Anaphylactoid and anaphylactic reactions to iodinated contrast material. Allergy 1999;54(Suppl 58):13-16
   PubMedGoogle Scholar
• Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 2000;12:205-13
   PubMedGoogle Scholar
• Bennett CL, Nebeker JR, Lyons EA, et al. The Research on Adverse Drug Events and Reports (RADAR) project. JAMA 2005;293:2131-40
   PubMed Web of Science ®Google Scholar
• Hauben M, Zhou X. Quantitative methods in pharmacovigilance: focus on signal detection. Drug Saf 2003;26:159-86
   PubMed Web of Science ®Google Scholar
• FDA. Adverse Event Reporting System. 2009. Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.html [Cited 24 November 2011]
   Google Scholar
• FDA. AERS Reporting by Healthcare Providers and Consumers by Year. 2010. Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm070456.html [Cited 24 November 2011]
   Google Scholar
• Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001;10:483-6
   PubMed Web of Science ®Google Scholar
• Falco FJ, Moran JG. Lumbar discography using gadolinium in patients with iodine contrast allergy followed by postdiscography computed tomography scan. Spine (Phila Pa 1976) 2003:28-E1-4
   Google Scholar
• Furuichi S, Yasuda S, Arita Y, et al. Gadopentetate dimeglumine as a potential alternative contrast medium during percutaneous coronary intervention: a case report. Circ J 2004;68:972-3
   PubMed Web of Science ®Google Scholar
• Newport JP, Dusseault BN, Butler C, et al. Gadolinium-enhanced computed tomography cystogram to diagnose bladder augment rupture in patients with iodine sensitivity. Urology 2008;71:984 e9-11
   PubMedGoogle Scholar
• Prince MR, Zhang H, Zou Z, et al. Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol 2011;196:W138-43
   Google Scholar
• Morcos SK. Review article: acute serious and fatal reactions to contrast media: our current understanding. Br J Radiol 2005;78:686-93
   PubMed Web of Science ®Google Scholar
• Meth MJ, Maibach HI. Current understanding of contrast media reactions and implications for clinical management. Drug Saf 2006;29:133-41
   PubMed Web of Science ®Google Scholar
• Jung JW, Kang HR, Kim MH, et al. Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology 2012;264:414-22
   PubMed Web of Science ®Google Scholar
• Murphy KJ, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR Am J Roentgenol 1996;167:847-9
   PubMed Web of Science ®Google Scholar
• Abujudeh HH, Kosaraju VK, Kaewlai R. Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections. AJR Am J Roentgenol 2010;194:430-4
   PubMed Web of Science ®Google Scholar
• Knopp MV, Balzer T, Esser M, et al. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use. Invest Radiol 2006;41:491-9
   PubMed Web of Science ®Google Scholar
• Kalogeromitros DC, Makris MP, Aggelides XS, et al. Anaphylaxis to gadobenate dimeglumine (Multihance): a case report. Int Arch Allergy Immunol 2007;144:150-4
   PubMed Web of Science ®Google Scholar
• Jordan RM, Mintz RD. Fatal reaction to gadopentetate dimeglumine. AJR Am J Roentgenol 1995;164:743-4
   PubMed Web of Science ®Google Scholar
• Witte RJ, Anzai LL. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine. AJNR Am J Neuroradiol 1994;15:523-4
   PubMed Web of Science ®Google Scholar
• Singer BD, Woodrick RS, Pedicano JB. Severe adverse drug reaction to gadobenate dimeglumine. ScientificWorldJournal 2009;9:363-5
   PubMed Web of Science ®Google Scholar
• Weiss KL. Severe anaphylactoid reaction after i.v. Gd-DTPA. Magn Reson Imaging 1990;8:817-18
   PubMed Web of Science ®Google Scholar
• Galera C, Pur Ozygit L, Cavigioli S, et al. Gadoteridol-induced anaphylaxis - not a class allergy. Allergy 2009;65:132-4
   PubMed Web of Science ®Google Scholar
• Hasdenteufel F, Luyasu S, Renaudin JM, et al. Anaphylactic shock after first exposure to gadoterate meglumine: two case reports documented by positive allergy assessment. J Allergy Clin Immunol 2008;121:527-8
   PubMed Web of Science ®Google Scholar
• Hazell L, Shakir SA. Under-reporting of adverse drug reactions : a systematic review. Drug Saf 2006;29:385-96
   PubMed Web of Science ®Google Scholar
• Moore N, Hall G, Sturkenboom M, et al. Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole. Pharmacoepidemiol Drug Saf 2003;12:271-81
   PubMed Web of Science ®Google Scholar
• Salonen OL. Case of anaphylaxis and four cases of allergic reaction following Gd-DTPA administration. J Comput Assist Tomogr 1990;14:912-13
   PubMed Web of Science ®Google Scholar
• Meuli RA, Maeder P. Life-threatening anaphylactoid reaction after iv injection of gadoterate meglumine. AJR Am J Roentgenol 1996;166:729
   PubMed Web of Science ®Google Scholar
• Hasdenteufel F, Luyasu S, Renaudin JM, et al. Anaphylactic shock after first exposure to gadoterate meglumine: two case reports documented by positive allergy assessment. J Allergy Clin Immunol 2008;121:527-8
   PubMed Web of Science ®Google Scholar
• Hasdenteufel F, Luyasu S, Renaudin JM, et al. Anaphylactic shock after first exposure to a macrocyclic gadolinium chelate: a few comments - Reply. J Allergy Clin Immunol 2008;122:216-17
   Web of Science ®Google Scholar
• Shepherd M, Lata S, Mani S, et al. Anaphylaxis to gadolinium radiocontrast: a case report and review of the literature. J La State Med Soc 2009;161:282-4
   PubMedGoogle Scholar
• Simons CW, Benouni S, Gibbon G, et al. Severe anaphylactoid shock secondary to gadolinium contrast media. Ann Allergy Asthma Immunol 2009;103:359-60
   PubMed Web of Science ®Google Scholar